Personalized Dose Guidance using Safe Bayesian Optimization

arXiv2210.16944MaRDI QIDQ6415564FDOQ6415564

Publication date: 30 October 2022

Abstract: This work considers the problem of personalized dose guidance using Bayesian optimization that learns the optimum drug dose tailored to each individual, thus improving therapeutic outcomes. Safe learning using interior point method ensures patient safety with high probability. This is demonstrated using the problem of learning the optimum bolus insulin dose in patients with type 1 diabetes to counteract the effect of meal consumption. Starting from no a priori information about the patients, our dose guidance algorithm is able to improve the therapeutic outcome (measured in terms of % time-in-range) without jeopardizing patient safety. Other potential healthcare applications are also discussed.

This page was built for publication: Personalized Dose Guidance using Safe Bayesian Optimization

Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q6415564)